We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
- Authors
Gil, A.; Lavilla, P.; Valencia, E.; Pintado, V.; Dupla, M. L.; Khamashta, M. A.; García-Puig, J.; Ortiz-Vázquez, J.
- Abstract
The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients. Fluconazole, 200 mg orally, was given on the first day, followed by 100 mg daily for 4 weeks. Clinical and mycological evaluation was performed in 31 patients at the end of treatment and 24 were also assessed after 8 weeks of starting treatment. In 1 patient fluconazole was discontinued, 5 patients were lost to follow-up and 6 patients died during the study. Clinical and mycological cure was achieved in all patients; in 31 of 36 patients the clinical picture resolved within a week. The cure was confirmed in 27 patients by oesophagoscopy. Two patients relapsed 1 month after stopping fluconazole but the reinstitution of therapy achieved cure. Asymptomatic fungal oropharynx colonization was evident in about 40% of patients during treatment and follow-up period. Fluconazole was well tolerated by all patients but mild to moderate increase of liver enzymes values occurred in 16. Treatment had to be discontinued in 1 patient with hepatic tuberculosis because of severe liver function abnormalities, but their relation with the drug was uncertain. Fluconazole is an effective and safe treatment of oesophageal candidiasis in AIDS patients.
- Subjects
AIDS; CANDIDIASIS; CLINICAL trials; COMPARATIVE studies; ESOPHAGUS diseases; RESEARCH methodology; MEDICAL cooperation; OPPORTUNISTIC infections; RESEARCH; EVALUATION research; DISEASE complications; FLUCONAZOLE; THERAPEUTICS
- Publication
Postgraduate Medical Journal, 1991, Vol 67, Issue 788, p548
- ISSN
0032-5473
- Publication type
journal article